Search results

Create the page "Antidepressant agents" on this wiki! See also the search results found.

Augmentation agent
...[major depressive disorder]] (MDD), where augmentation agents are added to antidepressant therapy to improve outcomes. ...neurotransmitter systems that are not sufficiently targeted by the primary antidepressant. This can involve the enhancement of neurotransmitter availability, alterat

3 KB (459 words) - 03:38, 30 March 2024
Releasing agent
Releasing agents function by increasing the amount of neurotransmitter available in the syna == Types of releasing agents ==

2 KB (308 words) - 17:56, 29 February 2024
Norepinephrine–dopamine releasing agent
...of [[norepinephrine]] and [[dopamine]] from the [[synaptic cleft]]. These agents are a subclass of [[psychoactive drugs]] that have various therapeutic appl ...f depression, especially in cases that have not responded to traditional [[antidepressant]] medications.

3 KB (409 words) - 16:27, 23 March 2024
Treatment-resistant depression
Treatment options for TRD include switching to a different antidepressant, augmentation with a second medication, and [[psychotherapy]]. More invasiv If a patient does not respond to an antidepressant, a different antidepressant can be tried. This can involve switching within the same class of drugs or

2 KB (309 words) - 08:50, 25 February 2024
Tzanck test
Treatment options for TRD include switching to a different antidepressant, augmentation with a second medication, and [[psychotherapy]]. More invasiv If a patient does not respond to an antidepressant, a different antidepressant can be tried. This can involve switching within the same class of drugs or

2 KB (309 words) - 19:05, 25 February 2024
Protriptyline
Protriptyline is a tricyclic antidepressant that was previously widely used in the therapy of major [[depression]]. Mos Protriptyline (proe trip' ti leen) is a tricyclic antidepressant which acts by inhibition of serotonin and norepinephrine reuptake within sy

2 KB (223 words) - 12:31, 26 April 2019
5-HT2 antagonists
'''5-HT2 antagonists''' are a class of [[pharmacology|pharmacological]] agents that act by blocking the action of [[serotonin]] (5-HT) on its [[5-HT2 rece ...kade of 5-HT2A receptors is particularly associated with antipsychotic and antidepressant effects, while the blockade of 5-HT2C receptors can affect appetite and moo

3 KB (420 words) - 03:23, 2 April 2024
Serotonin releasing agents
'''Serotonin releasing agents''' ('''SRAs''') are a type of [[drug]] that induces the release of [[seroto == Types of Serotonin Releasing Agents ==

2 KB (267 words) - 20:51, 29 February 2024
Monoamine oxidase inhibitors
...best known as powerful anti-depressants, as well as effective therapeutic agents for panic disorder and social phobia. They are particularly effective in tr ...or its intended purpose. This led to its development as the first MAOI and antidepressant.

2 KB (238 words) - 18:57, 24 February 2024
5-HT7 agonists
'''5-HT7 agonists''' are a class of pharmacological agents that act on the [[5-HT7 receptor]], one of the [[serotonin]] receptors. The ...gnition. The activation of 5-HT7 receptors is thought to contribute to the antidepressant and anxiolytic effects observed in preclinical studies.

3 KB (353 words) - 03:10, 2 April 2024
Norepinephrine–dopamine disinhibitor
...k) blockade of 5-HT2C), been reserved for describing newer, more selective agents in which disinhibition of norepinephrine and dopamine release is their"[[Ca

895 bytes (134 words) - 15:17, 21 March 2024
Methiothepin
...and 5-HT7, among others. Its action on these receptors contributes to its antidepressant, anxiolytic, and antiemetic properties. Methiothepin also exhibits affinity ...le in psychiatric disorders, as well as the development of new therapeutic agents targeting these receptors.

2 KB (321 words) - 03:20, 25 March 2024
ATC code N06
=={{anchor|N06A}}N06A [[Antidepressant]]s== =={{anchor|N06B}}N06B [[stimulant|Psychostimulant]]s, agents used for [[ADHD]] and [[nootropic]]s==

4 KB (521 words) - 18:32, 10 September 2019
Selegiline
...e duration of its effects in [[Parkinson disease]]. Selegiline is also an antidepressant, its mechanism of action being inhibition of dopamine reuptake from the syn {{antiparkinson agents}}

3 KB (354 words) - 23:06, 19 January 2024
Serotonin–norepinephrine–dopamine reuptake inhibitor
...me psychiatric disorders. SNDRI drugs are considered potential therapeutic agents in treating [[depression]], [[anxiety disorders]], and possibly other condi ...rimental. One example of an SNDRI is [[nomifensine]], which was used as an antidepressant but was withdrawn from the market due to adverse effects.

3 KB (352 words) - 15:53, 23 March 2024
Reversible inhibitors of MAO-A
...bility in the [[brain]]. This mechanism of action is associated with their antidepressant and anxiolytic effects.

3 KB (402 words) - 03:52, 2 April 2024
Sigmaergics
...ug addiction, and pain management. However, the clinical use of sigmaergic agents is limited by their side effects and the need for further research to fully ...ticancer properties. The challenge lies in developing selective sigmaergic agents that can modulate specific receptor subtypes without causing adverse effect

3 KB (466 words) - 16:19, 23 March 2024
Nortriptyline hydrochloride
...der]]. It is the active metabolite of [[amitriptyline]], another tricyclic antidepressant, and is thought to work by modulating the balance of neurotransmitters, inc ...ide range of medications, including other antidepressants, anticholinergic agents, [[CYP2D6]] inhibitors, and [[MAO inhibitors]]. Such interactions can incre

3 KB (394 words) - 00:54, 9 April 2024
Erythrohydrobupropion
'''Erythrohydrobupropion''' is a major active metabolite of the antidepressant and smoking cessation drug [[bupropion]]. It is formed from bupropion by th [[Category:Smoking cessation agents]]

2 KB (207 words) - 02:24, 23 February 2024
Arylalkanolamine
...serve as key intermediates in the synthesis of a wide range of therapeutic agents, including: ...ts]]: Certain arylalkanolamines are precursors to or active ingredients in antidepressant medications.

3 KB (445 words) - 17:48, 19 April 2024